An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (clinicaltrials.gov) - Aug 12, 2026 - P2 | N=26 | Terminated | Sponsor: Immunovant Sciences GmbH | N=108 ➔ 26 | Trial completion date: Nov 2028 ➔ Jul 2026 | Enrolling by invitation ➔ Terminated | Trial primary completion date: Nov 2028 ➔ Jul 2026; Sponsor Decision
Enrollment change • Trial completion date • Trial primary completion date • Trial termination
|